The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study
Lyu S, Li J, Wu M, He D, Fu T, Ni F, Tan X, Wu G, Pan B, Li L, Wang H, Zeng G, Ni Z, Tan W, Zong Y, Chen L, Liu P, Qin H, He P, Zhang L, An Y, Liang Z, Xie L, Li Y, Zhou M, Li Q, Zhao J, Fang B, Ma Y, Huang R, Guo W, Dong X, Huang X, MO G, Xia J, Xiao K, Zhao H, Kong X, Zhao H, Ma J, Gao P, Yang W, Han F, Dong Y, Ye L, Chen C, Bao Z, Liu Y, Zheng C, Miao L, Yao M, Wang W, Wei S, Li H, Luo F, Liang G, Li J, Zhang C, Dai L, Song L, Wang C, Wang S. The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study. Journal Of Aerosol Medicine And Pulmonary Drug Delivery 2021, 34: 383-391. PMID: 34129389, DOI: 10.1089/jamp.2021.0004.Peer-Reviewed Original ResearchConceptsIntensive care unitAerosol therapyAerosolized medicationsCohort studySide effectsShort-acting muscarinic antagonistsCombination of inhaled corticosteroidsChronic obstructive pulmonary disease exacerbationsIntensive care unit patientsSpontaneously breathing patientsAdult intensive care unit patientsAdult ICU patientsChinese ICUsBreathing patientsRespiratory supportMuscarinic antagonistInhaled corticosteroidsAdult patientsClinical outcomesMechanical ventilationDisease exacerbationUnit patientsCare unitConclusion:</i></b>ICU patientsThe efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis
Tan W, Xu D, Xu M, Wang Z, Dai B, Li L, Zhao H, Wang W, Kang J. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis. Therapeutic Advances In Respiratory Disease 2021, 15: 17534666211009407. PMID: 33888007, PMCID: PMC8071979, DOI: 10.1177/17534666211009407.Peer-Reviewed Original ResearchConceptsAcute hypoxemic respiratory failureAcute respiratory distress syndromeNon-invasive respiratory supportHypoxemic respiratory failureNon-intubated patientsNon-invasive ventilationRandomized controlled trialsNon-COVID-19 patientsCOVID-19 patientsRespiratory failureRespiratory supportIntubation rateReduced respiratory rateHigh-flow nasal oxygen therapyMortality rateNewcastle-Ottawa Quality Assessment ScaleMeta-analysisNasal oxygen therapyRespiratory distress syndromeNon-COVID-19Supplemental material sectionCochrane Central RegisterQuality Assessment ScaleLong durationRandom-effects model